Search Results - "Dorr, Robert T."
-
1
Pharmacokinetics and Safety of Green Tea Polyphenols after Multiple-Dose Administration of Epigallocatechin Gallate and Polyphenon E in Healthy Individuals
Published in Clinical cancer research (15-08-2003)“…Purpose: Green tea and green tea polyphenols have been shown to possess cancer preventive activities in preclinical model systems. In preparation for future…”
Get full text
Journal Article -
2
Mitochondrial-mediated disregulation of Ca2+ is a critical determinant of velcade (PS-341/bortezomib) cytotoxicity in myeloma cell lines
Published in Cancer research (Chicago, Ill.) (01-05-2005)“…The proteasome inhibitor bortezomib (also known as PS-341/Velcade) is a dipeptidyl boronic acid that has recently been approved for use in patients with…”
Get full text
Journal Article -
3
Characterization of novel diaryl oxazole-based compounds as potential agents to treat pancreatic cancer
Published in The Journal of pharmacology and experimental therapeutics (01-11-2009)“…A series of diaryl- and fluorenone-based analogs of the lead compound UA-62784 [4-(5-(4-methoxyphenyl)oxazol-2-yl)-9H-fluoren-9-one] was synthesized with the…”
Get more information
Journal Article -
4
Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cells
Published in Molecular cancer research (01-03-2012)“…Oxidative protein folding in the endoplasmic reticulum (ER) requires strict regulation of redox homeostasis. Disruption of the lumenal redox balance induces an…”
Get full text
Journal Article -
5
Magnetic Resonance Imaging Identifies Differential Response to Pro-Oxidant Chemotherapy in a Xenograft Model
Published in Translational oncology (01-06-2016)“…Abstract Induction of oxidative stress is a key component of cancer therapy. Pro-oxidant drugs have been demonstrated to enhance the efficacy of radiotherapy…”
Get full text
Journal Article -
6
UA62784, a novel inhibitor of centromere protein E kinesin-like protein
Published in Molecular cancer therapeutics (01-01-2009)“…Pancreatic carcinoma is the fourth leading cause of death from cancer. Novel targets and therapeutic options are needed to aid in the treatment of pancreatic…”
Get full text
Journal Article -
7
Ethonafide-induced cytotoxicity is mediated by topoisomerase II inhibition in prostate cancer cells
Published in The Journal of pharmacology and experimental therapeutics (01-06-2007)“…Ethonafide is an anthracene-containing derivative of amonafide that belongs to the azonafide series of anticancer agents. The lack of cross-resistance in…”
Get more information
Journal Article -
8
Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid
Published in Bioorganic & medicinal chemistry letters (15-08-2009)“…Novel derivatives of nordihydoguaiaretic acid were synthesized and tested for in vitro and in vivo anticancer activity. Synthesis of seven semi-synthetic…”
Get full text
Journal Article -
9
Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse
Published in Toxicon (Oxford) (01-12-2002)“…Larrea tridentata (Moc & Sess) Cov. (Zygophyllaceae) is an ethnobotanically important plant found in the American Southwest and northern Mexico. Although…”
Get full text
Journal Article -
10
Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors
Published in Cancer biology & therapy (01-01-2015)“…Gemcitabine based treatment is currently a standard first line treatment for patients with advanced pancreatic cancer, however overall survival remains poor,…”
Get full text
Journal Article -
11
Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon
Published in Biochemical pharmacology (15-09-2000)“…Imexon is an iminopyrrolidone derivative that has selective antitumor activity in multiple myeloma. The exact mechanism of imexon action is unknown. In human…”
Get full text
Journal Article -
12
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
Published in The oncologist (Dayton, Ohio) (01-02-1998)“…Background. Since its clinical introduction in 1981, carboplatin has proved a feasible alternative to cisplatin for the treatment of many solid tumors,…”
Get full text
Journal Article -
13
Design and Synthesis of a Novel DNA−DNA Interstrand Adenine−Guanine Cross-Linking Agent
Published in Journal of the American Chemical Society (23-05-2001)Get full text
Journal Article -
14
Melanocortin peptide therapeutics: Historical milestones, clinical studies and commercialization
Published in Peptides (New York, N.Y. : 1980) (01-04-2006)“…The melanocortins (MCs) are a family of multifunctional peptidergic hormones. Several superpotent, prolonged acting, enzymatically resistant, MC analogs have…”
Get full text
Journal Article -
15
Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma
Published in Blood (21-08-2014)“…Lymphoma cells are subject to higher levels of oxidative stress compared with their normal counterparts and may be vulnerable to manipulations of the cellular…”
Get full text
Journal Article -
16
Preventing the autophagic survival response by inhibition of calpain enhances the cytotoxic activity of bortezomib in vitro and in vivo
Published in Cancer chemotherapy and pharmacology (01-06-2013)“…Purpose Bortezomib, a first-generation proteasome inhibitor, induces an endoplasmic reticulum (ER) stress response, which ultimately leads to dysregulation of…”
Get full text
Journal Article -
17
The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers
Published in Investigational new drugs (01-12-2013)“…Summary Microtubule targeting agents are among the most widely used chemotherapeutics for both solid and hematological malignancies. This study characterizes…”
Get full text
Journal Article -
18
Synthesis and Antitumor Activity of Heterocycles Related to Carbendazim
Published in Journal of heterocyclic chemistry (01-01-2015)“…Three types of compounds were synthesized from carbendazim (1), a benzimidazole derivative (Scheme ). They included a group of esters at N1 prepared by…”
Get full text
Journal Article -
19
Anti-tumor activity and mechanism of action for a cyanoaziridine-derivative, AMP423
Published in Cancer chemotherapy and pharmacology (01-04-2012)“…Purpose Preclinical studies evaluated the anti-tumor activity and mechanism of action of AMP423, a naphthyl derivative of 2-cyanoaziridine-1-carboxamide with…”
Get full text
Journal Article -
20
Interaction of Dacarbazine and Imexon, In Vitro and In Vivo, in Human A375 Melanoma Cells
Published in Anticancer research (01-09-2011)“…We evaluated mechanisms of interaction between the alkyating agent dacarbazine (DTIC) and the pro-oxidant, imexon, in the human A375 melanoma cell line. The…”
Get full text
Journal Article